Related Experiment Video
Updated: May 17, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Biomarkers in Parkinson's Disease
Sarah M Brooker1, Paulina Gonzalez-Latapi1
1The Ken and Ruth Davee Neurology Department, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Abstract:
Parkinson's disease (PD) is a leading cause of disability worldwide, and there is a pressing need to develop therapeutics to slow or halt disease progression. The identification of reliable biomarkers of PD at all stages of disease will be a critical step toward optimizing diagnosis and therapeutic development. For PD, biomarkers could serve multiple important functions. There have been significant advances in biomarker development in PD in recent years, and in this review, the authors summarize the current state of the PD biomarker field covering major advances in fluid, tissue, and neuroimaging biomarkers.
More Related Videos
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview